We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies.
Present your Company
The DESERT ANGELS ™ welcomes applications from startup or early stage companies. We evaluate applications on an ongoing basis and meet monthly from September through June.
Present your company
Become a member
As a vibrant, growing organization, the DESERT ANGELS ™ welcomes new members. If you are an accredited investor with a tenacious appetite for helping early-stage companies succeed, we’d love to get to know you better at an upcoming dinner meeting.
It is safe to say that there would have been no Calimmune without the early support of the Desert Angels.
Many members of the DA share our passion and see the potential for gene therapy to transform healthcare and liberate patients from chronic and incurable diseases. Their investments have helped us grow this company to what it is today. We truly hope Calimmune’s work will be life-changing for the people we plan to serve and the investors that supported us.
Scottsdale-based ClickIPO Holdings LLC has raised $2 million as it continues to grow what it calls the first mobile, automated software that allows individual investors to participate in the IPO market from their smartphones. The money, part of a Series A round of funding, is from strategic and angel investors, including some local investors. The […]
For 16 years, University of Arizona’s technology business incubator, the Arizona Center for Innovation, has been responsible for helping to produce and promote more than 100 tech-focused startups at the UA Tech Park, propping up everything from aerospace to cybersecurity endeavors. “The resources to grow already exist in Southern Arizona, so they can continue to […]
The Arizona Bioindustry Association (AZBio) today announced that GT Medical Technologies, Inc. (GT MedTech) has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards. Approximately 400,000 Americans are newly diagnosed with some type of brain tumor each year. For decades, clinicians have sought better treatments for these patients that […]